Company intelligence / Profile preview
Guizhou Weikang Zifan Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guizhou Weikang Zifan Pharmaceutical is a China-based pharmaceutical company specializing in the processing and development of traditional Chinese herbal medicines. The company has contributed to research on Rhizoma Musae decoction, identifying active compounds and their mechanisms in osteoarthritis treatment using advanced analytical techniques. Their products are used both commercially and in ongoing preclinical research.
- Therapeutic areas
- Rheumatology
- Modalities
- Small moleculeHerbal medicine (Traditional Chinese Medicine)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Guizhou Weikang Zifan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guizhou Weikang Zifan Pharmaceutical.